NEWAMSTERDAM PHARMA COMPANY

Ticker: NAMS CUSIP: N62509109 Class: Stock

Swiss National Bank's Holding History (CIK: 0001582202)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 88,900 Value ($000) $3,119 Avg Close $36.39 Range $28.19 - $42.00

Q3 2025

Shares 87,100 Value ($000) $2,477 Avg Close $23.97 Range $17.97 - $28.91

Q2 2025

Shares 83,900 Value ($000) $1,519 Avg Close $18.24 Range $14.06 - $22.25

Q1 2025

Shares 70,900 Value ($000) $1,451 Avg Close $22.23 Range $17.18 - $26.80

Q4 2024

Shares 72,000 Value ($000) $1,850 Avg Close $21.24 Range $15.51 - $27.29

Q3 2024

Shares 35,100 Value ($000) $583 Avg Close $17.30 Range $15.19 - $21.48

Q2 2024

Shares 35,100 Value ($000) $674 Avg Close $20.06 Range $16.62 - $24.79

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	88,900	$3,119	$36.39	$28.19 - $42.00
Q3 2025	87,100	$2,477	$23.97	$17.97 - $28.91
Q2 2025	83,900	$1,519	$18.24	$14.06 - $22.25
Q1 2025	70,900	$1,451	$22.23	$17.18 - $26.80
Q4 2024	72,000	$1,850	$21.24	$15.51 - $27.29
Q3 2024	35,100	$583	$17.30	$15.19 - $21.48
Q2 2024	35,100	$674	$20.06	$16.62 - $24.79